Ep. 86 - The next big thing in multiple sclerosis treatment (with John Scagnelli, MD)

On today’s episode of the FLATLINING Podcast from Fulcrum Strategies, President and CEO Ron Howrigon and Matthew Handley talk to John Scagnelli, MD, about multiple sclerosis.  This disease has no known cause and no known cure, but there have been some incredible advancements in treatment over the past few decades.Dr. Scagnelli specializes in Multiple Sclerosis and Adult Neurology at Raleigh Neurology’s Durham and Raleigh offices. Dr. Scagnelli received his BS in Human Development from Cornell University in 2002. He earned his MD from the University of Miami, Miller School of Medicine in 2006. He then completed his Neurology Residency at the University of Rochester, Strong Memorial Hospital. Following this he was awarded a National Multiple Sclerosis Society Fellowship to study the clinical care and research of patients with multiple sclerosis and related disorders at the University of Virginia.  Dr. Scagnelli is a member of the National MS Society and the American Academy of Neurology. ---Listen to the FLATLINING Podcast from Fulcrum Strategies wherever you listen to podcasts and have every episode delivered to your email by subscribing at www.FLATLINING.net.---Follow Matthew on X and LinkedIn.Follow Ron on LinkedIn.---Fulcrum Strategies is a healthcare consulting firm specializing in payer contract negotiation and strategic planning for physician practices.  Our firm has helped over 5,000 physicians in groups of all sizes and specialties across the country to significantly improve their contract language and reimbursement rates, strategically plan for the future, and achieve business success.  Learn more at FSDOC.com. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.flatlining.net